<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-109802" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Infectious Scleritis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moshirfar</surname>
            <given-names>Majid</given-names>
          </name>
          <aff>University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ronquillo</surname>
            <given-names>Yasmyne</given-names>
          </name>
          <aff>Hoopes Vision Research Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Majid Moshirfar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasmyne Ronquillo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-109802.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Infectious scleritis is an inflammatory process of the sclera due to a microbial agent. In order to avoid the risk of enucleation or evisceration due to this condition, it must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of infectious scleritis and highlights the role of the interprofessional team in managing care for patients suffering from this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of infectious scleritis.</p></list-item><list-item><p>Review the risk factors for developing infectious scleritis.</p></list-item><list-item><p>Summarize the epidemiology of infectious scleritis.</p></list-item><list-item><p>Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by Infectious scleritis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=109802&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=109802">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-109802.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Scleritis is an inflammation of the sclera, the outer layer of the globe. Scleritis can concurrently involve the cornea, episclera, and uvea.<xref ref-type="bibr" rid="article-109802.r1">[1]</xref><xref ref-type="bibr" rid="article-109802.r2">[2]</xref><xref ref-type="bibr" rid="article-109802.r3">[3]</xref>&#x000a0;Symptoms of scleritis can involve focal or diffuse hyperemia, pain, and visual impairment. Although the majority of scleritis cases are due to an autoimmune etiology, approximately 5&#x000a0;to 10% of cases are infectious.<xref ref-type="bibr" rid="article-109802.r4">[4]</xref><xref ref-type="bibr" rid="article-109802.r5">[5]</xref><xref ref-type="bibr" rid="article-109802.r6">[6]</xref>&#x000a0;</p>
        <p>The clinical symptoms for both infectious and autoimmune scleritis can appear similar.&#x000a0;As a result, infectious cases may be managed as autoimmune, possibly worsening the outcome. To differentiate infectious from autoimmune scleritis, accurate history is crucial.<xref ref-type="bibr" rid="article-109802.r7">[7]</xref>&#x000a0;About 94% of patients (n=48) had a predisposing factor for the infection. The most common factor was previous ocular surgery (83%), particularly pterygium excision (57%), which was the majority of cases. Other correlated factors included prior accidental eye injury, use of radiation, and the use of an antineoplastic like mitomycin.<xref ref-type="bibr" rid="article-109802.r8">[8]</xref>&#x000a0;Several organisms have been identified as agents for infectious scleritis, with <italic toggle="yes">Pseudomonas aeruginosa</italic> reported as the most common organism in developed countries.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref><xref ref-type="bibr" rid="article-109802.r7">[7]</xref><xref ref-type="bibr" rid="article-109802.r8">[8]</xref>&#x000a0;</p>
        <p>Other known vectors include bacteria or fungal organisms such as <italic toggle="yes">Nocardia, Streptococcus, Haemophilus, Candida, </italic>and<italic toggle="yes"> Aspergillus.</italic><xref ref-type="bibr" rid="article-109802.r9">[9]</xref><italic toggle="yes">&#x000a0;</italic>Untreated, infectious scleritis can result in the loss of the eye due to the spread of infection to surrounding structures or perforation of the globe.</p>
      </sec>
      <sec id="article-109802.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of infectious scleritis can be primary or secondary. Primary scleritis occurs following an accidental or surgical injury (58.5&#x000a0;to 88%).<xref ref-type="bibr" rid="article-109802.r10">[10]</xref><xref ref-type="bibr" rid="article-109802.r11">[11]</xref>&#x000a0;Infectious scleritis can follow trauma (10%), infectious endophthalmitis, or adjacent keratitis. Predisposing factors to a primary infection include systemic infection, systemic/topical steroid use (39%), and previous diagnosis of autoimmune scleritis. Ocular surgery such as pterygium surgery (57%), scleral buckle (8%), cataract removal (10%), strabismus, glaucoma filtration surgery, suture removal, and vitreoretinal procedures have all been implicated for infectious scleritis.<xref ref-type="bibr" rid="article-109802.r12">[12]</xref><xref ref-type="bibr" rid="article-109802.r13">[13]</xref><xref ref-type="bibr" rid="article-109802.r14">[14]</xref><xref ref-type="bibr" rid="article-109802.r15">[15]</xref><xref ref-type="bibr" rid="article-109802.r16">[16]</xref>&#x000a0;</p>
        <p>A&#x000a0;cosmetic ocular-whitening procedure, popularized in South Korea, has also been noted to lead to infectious scleritis. The procedure involves the removal of pinguecula or pterygium and is followed by an amniotic membrane graft. One severe post-procedural complication is a scleral melt, which puts the patient at high risk for infectious scleritis.<xref ref-type="bibr" rid="article-109802.r17">[17]</xref>&#x000a0;Secondary infectious scleritis refers to the extension of a primary corneal infection (corneoscleritis). Risk factors for corneoscleritis include similar risk factors for primary infectious scleritis, such as suture removal or ocular surgeries. Further risk factors noted specifically for secondary infectious scleritis are contact lenses use, debilitating systemic diseases, and corneal tissue devitalization.</p>
      </sec>
      <sec id="article-109802.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>One study reported that in 56 eyes with infectious scleritis, the median time from the inciting event was 1.9 months. Patients with a history of pterygium surgery had a median time of 49 months (range 0-183 months) after surgery before developing infectious scleritis. This duration is significantly longer than those with glaucoma, cataracts, and retinal surgery (median 1.0&#x000a0;to 1.6 months). The study also noted a median age of 70, suggesting that age might be a factor in developing this condition.<xref ref-type="bibr" rid="article-109802.r7">[7]</xref>&#x000a0;The pathogens more commonly responsible for infectious scleritis are&#x000a0;<italic toggle="yes">Pseudomonas aeruginosa </italic>in developed countries and&#x000a0;<italic toggle="yes">Nocardia</italic> or fungi in developing countries.<xref ref-type="bibr" rid="article-109802.r1">[1]</xref></p>
      </sec>
      <sec id="article-109802.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The most common cause of infectious scleritis is&#x000a0;<italic toggle="yes">Pseudomonas </italic>spp, with <italic toggle="yes">Pseudomonas aeruginosa</italic> being the most frequent. This pathogen uses collagenases to destroy the scleral tissue.<xref ref-type="bibr" rid="article-109802.r18">[18]</xref>&#x000a0;This microbe is the etiologic agent for 25-85% of cases in some studies.<xref ref-type="bibr" rid="article-109802.r5">[5]</xref><xref ref-type="bibr" rid="article-109802.r6">[6]</xref>&#x000a0;The next common cause of bacterial scleritis is gram-positive cocci. <italic toggle="yes">Staphylococcus aureus</italic> causes localized scleral thinning and inverse hypopyon.<xref ref-type="bibr" rid="article-109802.r19">[19]</xref>&#x000a0;Methicillin-resistant <italic toggle="yes">Staphylococcus aureus&#x000a0;</italic>(MRSA) has also been noted in cases of post-surgical infectious scleritis, incorrectly diagnosed as <italic toggle="yes">Pseudomonas.<xref ref-type="bibr" rid="article-109802.r20">[20]</xref></italic>&#x000a0;<italic toggle="yes">Streptococcus</italic> has been noted in patients with simultaneous cardiovascular, gastrointestinal, and genitourinary infections. Additional predisposing factors are the use of radiation and mitomycin C.<xref ref-type="bibr" rid="article-109802.r8">[8]</xref>&#x000a0;</p>
        <p>Several cases due to <italic toggle="yes">S. pneumoniae </italic>were refractory to antibiotics and resulted in enucleation, suggesting an aggressive form of infectious scleritis.&#x000a0;Gram-negative bacilli are another common cause of infectious scleritis. One patient with a gram-negative bacilli infection presented with a mass over an area of the sclera, which was discovered by ultrasound biomicroscopy (UBM) 18 years after pterygium surgery.&#x000a0;Other reported etiologic agents for infectious scleritis are <italic toggle="yes">Mycobacterium tuberculosis, Klebsiella, Rhodtrula, </italic>and other <italic toggle="yes">Mycobacterial</italic> infections in the immunocompromised.<xref ref-type="bibr" rid="article-109802.r10">[10]</xref></p>
        <p>Fungal infectious scleritis has a worse outcome compared to bacterial or viral scleritis. Poor outcomes for fungal scleritis may be explained by the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fungal infections take longer to diagnose than bacterial infections.</p>
          </list-item>
          <list-item>
            <p>Antifungals have poor penetration into the sclera.</p>
          </list-item>
          <list-item>
            <p>Fungal infections are more aggressive.</p>
          </list-item>
        </list>
        <p>A majority of cases progress to the evisceration of the eye.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref><xref ref-type="bibr" rid="article-109802.r10">[10]</xref>&#x000a0;<italic toggle="yes">Nocardia</italic> is classified with fungal scleritis because the findings are more similar to fungal scleritis than bacterial scleritis. Additionally, fungal etiology should be considered in developing countries. The study hypothesized that fungal infections are more likely to occur in hot/arid climates, allowing for a higher presence in the soil, and are due to inciting factors of trauma or surgery. Signs of fungal scleritis include full-thickness corneal inflammation with scleral lesions, rapidly progressive cataracts, and serous retinal detachment.<xref ref-type="bibr" rid="article-109802.r5">[5]</xref><xref ref-type="bibr" rid="article-109802.r9">[9]</xref>&#x000a0;Exposure to agricultural soil or plant matter is an inciting factor for infections with <italic toggle="yes">Nocardia</italic>, <italic toggle="yes">Psuedallescheria boydii</italic>, and <italic toggle="yes">Paecilomyces lilacinus</italic>. <italic toggle="yes">Aspergillus</italic> was noted to be found in a patient with a history of intravenous drug use (IVDA).&#x000a0;<italic toggle="yes">Scedosporium </italic>is another fungal vector<italic toggle="yes">.</italic></p>
        <p>Other forms of infectious scleritis result from viruses and parasites. Among the parasites, the most notable is <italic toggle="yes">Toxoplasma gondii</italic>. In one study, patients with this pathogen had retinochoroiditis and were immunosuppressed on the diagnosis.<xref ref-type="bibr" rid="article-109802.r21">[21]</xref>&#x000a0;Viral scleritis has been noted with both VZV and HSV, typically with unilateral symptoms.&#x000a0;The severity of symptoms in viral scleritis has been variable, but most studies describe the presence of a diffuse anterior scleritis, perilimbal devascularization, and corneal thinning.<xref ref-type="bibr" rid="article-109802.r22">[22]</xref></p>
      </sec>
      <sec id="article-109802.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients suspected of having scleritis should have a thorough systemic evaluation and a full ophthalmic examination.<xref ref-type="bibr" rid="article-109802.r22">[22]</xref>&#x000a0;A history of trauma or ocular surgery should alert the physician. Patients presenting with infectious scleritis usually complain of redness, watery eyes, and pain.<xref ref-type="bibr" rid="article-109802.r13">[13]</xref>&#x000a0;Patients with infectious scleritis and history of retinal surgery generally have a more rapid onset when compared to other groups.<xref ref-type="bibr" rid="article-109802.r14">[14]</xref></p>
        <p>On examination, patients commonly have episcleral and conjunctival hyperemia (98%), and scleral necrosis (93%). Patients additionally present with calcified plaques (38%), anterior segment inflammation (25%), corneal involvement (25%), and multifocal scleral abscesses (23%).<xref ref-type="bibr" rid="article-109802.r4">[4]</xref>&#x000a0;Studies also report cases with adjacent structure involvement or endophthalmitis on presentation. One study noted that the mean necrotic area was 3.6 clock hours. The area was smaller in patients that lacked an inciting event. Bacterial scleritis was also reported to have a larger necrotic area when compared to fungal scleritis on presentation.<xref ref-type="bibr" rid="article-109802.r4">[4]</xref>&#x000a0;Peripheral keratitis was more frequently seen in patients with infectious scleritis&#x000a0;than those with idiopathic scleritis (22.9%/10.3%).<xref ref-type="bibr" rid="article-109802.r22">[22]</xref>&#x000a0;Unilateral sclerouveitis or sclerokeratitis may have an underlying infection, especially if there are no symptoms of systemic disease.</p>
        <p>The use of ultrasound biomicroscopy (UBM) has also been used for the examination of infectious scleritis. UBM allows for early detection of choroidal and retinal detachment, ciliary body rotation, and elimination of the ciliary sulcus due to infectious scleritis.<xref ref-type="bibr" rid="article-109802.r23">[23]</xref>&#x000a0;Additionally, imaging via optical coherence tomography could also allow for the visualization of vitreous opacities and subretinal deposits, suggestive of lipofuscin-laden macrophages.</p>
      </sec>
      <sec id="article-109802.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patients with newly-diagnosed scleritis should undergo clinical and laboratory evaluation for vasculitis, including CBC, CMP, urinalysis, P-ANCA, C-ANCA, ESR, C-reactive protein, and chest x-ray. Systemic infections such as Lyme disease or syphilis must also be ruled out.<xref ref-type="bibr" rid="article-109802.r24">[24]</xref>&#x000a0;</p>
        <p>Patients with a high-risk history should be further evaluated for infectious scleritis. Infectious scleritis should be cultured by swab, spatula, or biopsy of the sclera. Specimens should be cultured on blood and chocolate agar, thioglycolate, Sabourad dextrose agar, non-nutrient agar with <italic toggle="yes">E.Coli</italic>, and brain- heart infusion broth.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref>&#x000a0;Additional methods, such as immunohistochemistry and titers, should also be utilized for culture-negative results.<xref ref-type="bibr" rid="article-109802.r14">[14]</xref><xref ref-type="bibr" rid="article-109802.r22">[22]</xref></p>
      </sec>
      <sec id="article-109802.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Studies have highlighted the importance of the prevention of infectious scleritis.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref>&#x000a0;Measures like adjunctive therapy or avoiding overuse of cautery during surgery might spare episcleral blood flow, allowing for better wound healing.<xref ref-type="bibr" rid="article-109802.r25">[25]</xref>&#x000a0;Studies also advise against the bare sclera techniques as these&#x000a0;leave the surface vulnerable to infection. Studies also advise against the use of an amniotic membrane over an area of debridement as it affects the penetration of antimicrobial agents, though they advocate the combined use of an amniotic membrane and fascia lata grafts over an area of debridement.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref>&#x000a0;Recommendations for infectious scleritis treatment are not well established before a specific antimicrobial diagnosis.<xref ref-type="bibr" rid="article-109802.r5">[5]</xref>&#x000a0;Initial treatment with a broad-spectrum antibiotic coverage for <italic toggle="yes">Pseudomonas</italic>, both topical (gatifloxacin 0.3% and amikacin 2.5%) as well as systemic (gatifloxacin 400mg twice daily), maybe started to address a clinical suspicion of Pseudomonas.<xref ref-type="bibr" rid="article-109802.r4">[4]</xref><xref ref-type="bibr" rid="article-109802.r13">[13]</xref>&#x000a0;</p>
        <p>If history is indicative of trauma with agricultural material, a topical and systemic antifungal should be used.<xref ref-type="bibr" rid="article-109802.r10">[10]</xref>&#x000a0;There is no strict guideline for the duration of the antimicrobial medication. One source states a median amount of 50 days for infectious scleritis while another recommends a &#x0201c;prolonged&#x0201d; course.<xref ref-type="bibr" rid="article-109802.r5">[5]</xref><xref ref-type="bibr" rid="article-109802.r25">[25]</xref></p>
        <p>As broad-spectrum antibiotic coverage is generally used for the most common causative organisms, studies recommend tailoring the treatment to culture results. Scleritis due to <italic toggle="yes">Staphylococcus</italic> and <italic toggle="yes">Streptococcus</italic> may be treated with topical antibiotics such as fortified cefazolin (50 mg/mL) and topical fluoroquinolones (ciprofloxacin 0.3%/gatifloxacin 0.3%).<xref ref-type="bibr" rid="article-109802.r13">[13]</xref>&#x000a0;Patients refractory to fortified antibiotic therapy or culture positive for MRSA may be admitted and treated with subconjunctival and IV vancomycin.<xref ref-type="bibr" rid="article-109802.r5">[5]</xref>&#x000a0;</p>
        <p>Tuberculosis therapy is recommended for patients with <italic toggle="yes">M.tuberculosis </italic>scleritis. However, those with other <italic toggle="yes">Mycobacterium</italic> do not respond well to antituberculosis medications and should be treated with topical amikacin (25 mg/mL) and a systemic medication such as doxycycline (200 mg) or clarithromycin (500 mg). It is also recommended to continue the medication four to six weeks after the resolution of symptoms.&#x000a0;Topical natamycin 5% and systemic itraconazole (100 mg) or systemic ketoconazole (200 mg) twice daily&#x000a0;are recommended for patients with a fungal scleritis. <italic toggle="yes">Nocardia</italic> shows good resolution with the use of systemic trimethoprim/sulfamethoxazole (160 mg/800 mg twice daily), but some studies have also shown sensitivity to topical amikacin.<xref ref-type="bibr" rid="article-109802.r5">[5]</xref><xref ref-type="bibr" rid="article-109802.r6">[6]</xref>&#x000a0;</p>
        <p>Patients diagnosed with <italic toggle="yes">Toxoplasmosis gondii </italic>show good resolution with an oral trimethoprim/sulfamethoxazole (160 mg/800 mg twice daily) and azithromycin (500 mg); however, no topical application was reported.<xref ref-type="bibr" rid="article-109802.r26">[26]</xref>&#x000a0;varicella-zoster virus (VZV) or herpes simplex virus (HSV) scleritis showed resolution with acyclovir treatments (initial 800 mg five times daily with lower maintenance dose).<xref ref-type="bibr" rid="article-109802.r22">[22]</xref>&#x000a0;It is noted that while an oral steroid with antimicrobials has varying success, it has been detrimental for cases of <italic toggle="yes">Nocardia </italic>and HSV.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref></p>
        <p>Studies indicate that a variety of antimicrobial treatment regimens have been utilized (95% topical, 77% oral, 11% intravitreal). However, in only 18% of patients (n=56), was this sole treatment adequate, most who received this treatment required surgical intervention.<xref ref-type="bibr" rid="article-109802.r7">[7]</xref>&#x000a0;Another study (n=28) found that three out of four patients receiving medical therapy alone (n=16) result in enucleation or evisceration of the eye, whereas combined intervention (n=11) results in two out of eleven patients needing enucleation or evisceration of the eye.<xref ref-type="bibr" rid="article-109802.r12">[12]</xref>&#x000a0;Most patients with a diagnosis of infectious scleritis should undergo early and repetitive surgical debridement.<xref ref-type="bibr" rid="article-109802.r4">[4]</xref><xref ref-type="bibr" rid="article-109802.r8">[8]</xref><xref ref-type="bibr" rid="article-109802.r13">[13]</xref>&#x000a0;</p>
        <p>Cryotherapy, corneoscleral grafts, or removal of hardware (scleral buckle and glaucoma drainage device), in addition to antimicrobial medication, may be necessary.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref><xref ref-type="bibr" rid="article-109802.r7">[7]</xref>&#x000a0;Surgeries are adjunctive methods to overcome the poor penetration of the antimicrobial agent. Studies show that if patients were diagnosed and started on surgical treatment within a specific time frame (2.5 days) from diagnoses, patients had a 100% globe preservation rate.<xref ref-type="bibr" rid="article-109802.r27">[27]</xref></p>
      </sec>
      <sec id="article-109802.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The most common differential diagnosis for patients with suspected infectious scleritis is autoimmune scleritis, as both manifest with similar signs and symptoms.<xref ref-type="bibr" rid="article-109802.r2">[2]</xref><xref ref-type="bibr" rid="article-109802.r10">[10]</xref>&#x000a0;Alternate diagnoses include episcleritis and anterior uveitis.<xref ref-type="bibr" rid="article-109802.r15">[15]</xref><xref ref-type="bibr" rid="article-109802.r28">[28]</xref>&#x000a0;Patients with systemic diseases such as vasculitis and syphilis have also been known to show symptoms similar to scleritis. A systemic workup can differentiate these from scleritis.<xref ref-type="bibr" rid="article-109802.r24">[24]</xref></p>
      </sec>
      <sec id="article-109802.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Worse visual outcomes are correlated with poor visual acuity at presentation, endophthalmitis, keratitis, isolated medical therapy, and fungal infections.<xref ref-type="bibr" rid="article-109802.r29">[29]</xref>&#x000a0;The dissemination of the infection also leads to a worse outcome. A study reported that 50% of eyes lost function vision, meaning best-corrected visual acuity of less than 20/200.&#x000a0;No difference in outcome has been noted for the duration of treatment, bacterial infection/fungal infection, or inciting event.<xref ref-type="bibr" rid="article-109802.r7">[7]</xref></p>
      </sec>
      <sec id="article-109802.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Poorly managed cases or undiagnosed infectious scleritis may result in poor outcomes for patients. As previously stated, treatment with steroids may worsen the infection. Recurrence of infectious scleritis, defined as new nodules or necrotic areas, were seen in 9.52% of patients, most of which had fungal scleritis.<xref ref-type="bibr" rid="article-109802.r6">[6]</xref><xref ref-type="bibr" rid="article-109802.r10">[10]</xref><xref ref-type="bibr" rid="article-109802.r30">[30]</xref>&#x000a0;Other complications included cataracts, glaucoma, epithelial defects, fibrotic pupillary membrane, corneal opacities, retinal detachment, choroidal detachment, and globe perforation. Some complications may require enucleation.<xref ref-type="bibr" rid="article-109802.r10">[10]</xref><xref ref-type="bibr" rid="article-109802.r13">[13]</xref></p>
      </sec>
      <sec id="article-109802.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>To prevent infectious scleritis, measures to ensure optimal surgical technique, infectious disease protocol adherence, and proper ocular follow up should be stressed. The majority of infectious scleritis cases are associated with pterygium excision and other ocular surgeries. Although such complications are rare, patients who undergo these surgeries should be made aware of the outcomes and risks associated with these procedures during the process of informed consent.</p>
      </sec>
      <sec id="article-109802.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Infectious scleritis&#x000a0;may be undiagnosed due to the similarity of findings with autoimmune scleritis.</p>
          </list-item>
          <list-item>
            <p>Systemic signs and symptoms must be investigated before diagnosing infectious scleritis.</p>
          </list-item>
          <list-item>
            <p>Infectious scleritis has inciting factors of trauma or ocular surgery.</p>
          </list-item>
          <list-item>
            <p>The best course of treatment is early detection, directed antimicrobial therapy, and surgical debridement.</p>
          </list-item>
          <list-item>
            <p>Late diagnosis or misdiagnosis can lead to poor visual outcomes, including enucleation.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-109802.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Regular&#x000a0;follow-up and visual testing after high-risk ocular surgeries would lead to better outcomes. A diagnosis of infectious scleritis may&#x000a0;be missed due to similarities with autoimmune scleritis. The health care team should document any unexpected or worsening of the clinical picture after ocular surgeries and refer immediately to the attending ophthalmologist or surgeon for immediate evaluation and further treatment.</p>
      </sec>
      <sec id="article-109802.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=109802&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=109802">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/infectious-scleritis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=109802">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/109802/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=109802">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-109802.s16">
        <title>References</title>
        <ref id="article-109802.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Microbial scleritis-experience from a developing country.</article-title>
            <source>Eye (Lond)</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>255</fpage>
            <page-range>255-61</page-range>
            <pub-id pub-id-type="pmid">18219336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okhravi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Odufuwa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McCluskey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Scleritis.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2005</year>
            <season>Jul-Aug</season>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>351</fpage>
            <page-range>351-63</page-range>
            <pub-id pub-id-type="pmid">15967190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sainz de la Maza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jabbur</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Severity of scleritis and episcleritis.</article-title>
            <source>Ophthalmology</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>101</volume>
            <issue>2</issue>
            <fpage>389</fpage>
            <page-range>389-96</page-range>
            <pub-id pub-id-type="pmid">8115160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Hui-Kang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Infectious scleritis in Taiwan-a 10-year review in a tertiary-care hospital.</article-title>
            <source>Cornea</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>8</issue>
            <fpage>838</fpage>
            <page-range>838-43</page-range>
            <pub-id pub-id-type="pmid">24977990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerrero-Wooley</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Peacock</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Infectious Scleritis: What the ID Clinician Should Know.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>ofy140</fpage>
            <pub-id pub-id-type="pmid">29977974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramenaden</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Raiji</surname>
                <given-names>VR</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and visual outcomes in infectious scleritis: a review.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2013</year>
            <volume>7</volume>
            <fpage>2113</fpage>
            <page-range>2113-22</page-range>
            <pub-id pub-id-type="pmid">24235809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hodson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Galor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karp</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Albini</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Forster</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and visual outcomes in patients with infectious scleritis.</article-title>
            <source>Cornea</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>466</fpage>
            <page-range>466-72</page-range>
            <pub-id pub-id-type="pmid">22902495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paula</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sim&#x000e3;o</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rocha</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Rom&#x000e3;o</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Velasco Cruz</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Atypical pneumococcal scleritis after pterygium excision: case report and literature review.</article-title>
            <source>Cornea</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-7</page-range>
            <pub-id pub-id-type="pmid">16331053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahn</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Wee</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population.</article-title>
            <source>Korean J Ophthalmol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>331</fpage>
            <page-range>331-5</page-range>
            <pub-id pub-id-type="pmid">21165230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Risk factors and clinical outcomes of bacterial and fungal scleritis at a tertiary eye care hospital.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2015</year>
            <season>Apr-Jun</season>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-11</page-range>
            <pub-id pub-id-type="pmid">25949079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sainz de la Maza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hemady</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Infectious scleritis: report of four cases.</article-title>
            <source>Doc Ophthalmol</source>
            <year>1993</year>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-41</page-range>
            <pub-id pub-id-type="pmid">8334918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reynolds</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Alfonso</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Treatment of infectious scleritis and keratoscleritis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1991</year>
            <month>Nov</month>
            <day>15</day>
            <volume>112</volume>
            <issue>5</issue>
            <fpage>543</fpage>
            <page-range>543-7</page-range>
            <pub-id pub-id-type="pmid">1951592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar Sahu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sahu</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinico-microbiological profile and treatment outcome of infectious scleritis: experience from a tertiary eye care center of India.</article-title>
            <source>Int J Inflam</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>753560</fpage>
            <pub-id pub-id-type="pmid">22164345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rich</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Smiddy</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Infectious scleritis after retinal surgery.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>145</volume>
            <issue>4</issue>
            <fpage>695</fpage>
            <page-range>695-9</page-range>
            <pub-id pub-id-type="pmid">18241830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watson</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Scleritis and episcleritis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1976</year>
            <month>Mar</month>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>163</fpage>
            <page-range>163-91</page-range>
            <pub-id pub-id-type="pmid">1268179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kearney</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Blaikie</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Gole</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Anterior necrotizing scleritis after strabismus surgery in a child.</article-title>
            <source>J AAPOS</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-8</page-range>
            <pub-id pub-id-type="pmid">17416330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moshirfar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McCaughey</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Fenzl</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Santiago-Caban</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Mamalis</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Delayed manifestation of bilateral scleral thinning after I-BRITE(&#x000ae;) procedure and review of literature for cosmetic eye-whitening procedures.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2015</year>
            <volume>9</volume>
            <fpage>445</fpage>
            <page-range>445-51</page-range>
            <pub-id pub-id-type="pmid">25784790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meallet</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Subpalpebral lavage antibiotic treatment for severe infectious scleritis and keratitis.</article-title>
            <source>Cornea</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>159</fpage>
            <page-range>159-63</page-range>
            <pub-id pub-id-type="pmid">16371774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arora</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shroff</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Inverse hypopyon as the presenting feature of infectious scleritis in a case of tropical pyomyositis.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>769</fpage>
            <page-range>769-71</page-range>
            <pub-id pub-id-type="pmid">17224963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Oum</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Methicillin-resistant Staphylococcus aureus sclerokeratitis after pterygium excision.</article-title>
            <source>Cornea</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>744</fpage>
            <page-range>744-6</page-range>
            <pub-id pub-id-type="pmid">17592329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schuman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Ferry</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Guerry</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Toxoplasmic scleritis.</article-title>
            <source>Ophthalmology</source>
            <year>1988</year>
            <month>Oct</month>
            <volume>95</volume>
            <issue>10</issue>
            <fpage>1399</fpage>
            <page-range>1399-403</page-range>
            <pub-id pub-id-type="pmid">3226688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalez-Gonzalez</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Molina-Prat</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Doctor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tauber</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sainz de la Maza</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases.</article-title>
            <source>Ophthalmology</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>119</volume>
            <issue>7</issue>
            <fpage>1460</fpage>
            <page-range>1460-4</page-range>
            <pub-id pub-id-type="pmid">22463821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yiu</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Imaging studies in a case of infectious scleritis after pterygium excision.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2012</year>
            <season>Jul-Sep</season>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>337</fpage>
            <page-range>337-9</page-range>
            <pub-id pub-id-type="pmid">22837631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sainz de la Maza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jabbur</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Scleritis associated with systemic vasculitic diseases.</article-title>
            <source>Ophthalmology</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>102</volume>
            <issue>4</issue>
            <fpage>687</fpage>
            <page-range>687-92</page-range>
            <pub-id pub-id-type="pmid">7724185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsiao</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Intrascleral dissemination of infectious scleritis following pterygium excision.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>82</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">9536876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamath</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Rathinam</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kawali</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ocular toxoplasmosis associated with scleritis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>295</fpage>
            <page-range>295-7</page-range>
            <pub-id pub-id-type="pmid">23619485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tittler</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rue</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Vasconcelos-Santos</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Irvine</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Yiu</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Early surgical debridement in the management of infectious scleritis after pterygium excision.</article-title>
            <source>J Ophthalmic Inflamm Infect</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-7</page-range>
            <pub-id pub-id-type="pmid">22354483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sainz de la Maza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jabbur</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Scleritis-associated uveitis.</article-title>
            <source>Ophthalmology</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>104</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-63</page-range>
            <pub-id pub-id-type="pmid">9022105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pradhan</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Infectious scleritis: clinical spectrum and management outcomes in India.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>61</volume>
            <issue>10</issue>
            <fpage>590</fpage>
            <page-range>590-3</page-range>
            <pub-id pub-id-type="pmid">24212312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-109802.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bin Ismail</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>RHF</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>EPY</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Teoh</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)-report 4: analysis and outcome of scleritis in an East Asian population.</article-title>
            <source>J Ophthalmic Inflamm Infect</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">28205148</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
